Cargando…

The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline

The Face-Name Associative Memory Exam (FNAME) is a paired associative memory test created to detect memory deficits in individuals with preclinical Alzheimer’s disease (AD). Worse performance on FNAME in cognitively healthy individuals were found related to higher amyloid beta (Aβ) burden measured w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanabria, Angela, Alegret, Montserrat, Rodriguez-Gomez, Octavio, Valero, Sergi, Sotolongo-Grau, Oscar, Monté-Rubio, Gemma, Abdelnour, Carla, Espinosa, Ana, Ortega, Gemma, Perez-Cordon, Alba, Gailhajanet, Anna, Hernandez, Isabel, Rosende-Roca, Maitee, Vargas, Liliana, Mauleon, Ana, Sanchez, Domingo, Martin, Elvira, Rentz, Dorene M., Lomeña, Francisco, Ruiz, Agustin, Tarraga, Lluis, Boada, Merce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830648/ https://www.ncbi.nlm.nih.gov/pubmed/29491481 http://dx.doi.org/10.1038/s41598-018-21644-y

Ejemplares similares

A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease
por: Alegret, Montserrat, et al.
Publicado: (2020)

Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
por: Pérez-Cordón, Alba, et al.
Publicado: (2020)

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic
por: Cañabate, Pilar, et al.
Publicado: (2017)

From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery
por: Alegret, Montserrat, et al.
Publicado: (2021)

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2013)

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2014)

Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
por: Alegret, Montserrat, et al.
Publicado: (2022)

Genome-wide significant risk factors on chromosome 19 and the APOE locus
por: Moreno-Grau, Sonia, et al.
Publicado: (2018)

Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Sergi, Valero, et al.
Publicado: (2020)

Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Valero, Sergi, et al.
Publicado: (2021)

Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
por: Marquié, Marta, et al.
Publicado: (2020)

Visual impairment in aging and cognitive decline: experience in a Memory Clinic
por: Marquié, Marta, et al.
Publicado: (2019)

Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic
por: Sánchez, Domingo, et al.
Publicado: (2020)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
por: Roberto, Natalia, et al.
Publicado: (2021)

Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2018)

Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2019)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
por: Roberto, Natalia, et al.
Publicado: (2021)

Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain
por: Benaque, Alba, et al.
Publicado: (2020)

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
por: de Rojas, Itziar, et al.
Publicado: (2018)

Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
por: Ortega, G., et al.
Publicado: (2021)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2022)

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research
por: Boada, Mercè, et al.
Publicado: (2018)

The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
por: Marquié, Marta, et al.
Publicado: (2023)

I know your face but can’t remember your name: Age-related differences in the FNAME-12NL
por: Enriquez-Geppert, S, et al.
Publicado: (2020)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
por: Muñoz, Nathalia, et al.
Publicado: (2020)

The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening
por: Rosende-Roca, Maitee, et al.
Publicado: (2021)

BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
por: Esteban de Antonio, Ester, et al.
Publicado: (2021)

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2023)

Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
por: Orellana, Adelina, et al.
Publicado: (2022)

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
por: Morató, Xavier, et al.
Publicado: (2023)

Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging
por: Rentz, Dorene M., et al.
Publicado: (2023)

Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer’s Disease Dementia: A Latent Class Analysis
por: Rosende-Roca, Maitée, et al.
Publicado: (2022)

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
por: Pérez-Grijalba, Virginia, et al.
Publicado: (2019)

Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project
por: Rodrigo, Adrián, et al.
Publicado: (2021)

Validating Use of Technology for Cognitive Test Assessment
por: Rentz, Dorene M.
Publicado: (2016)

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
por: Lacour, A, et al.
Publicado: (2017)

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype
por: Espinosa, Ana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_395u0f395i1u6bs0fkv5j1m8uf